New Thai Health Minister Promises To Break Drug Patents
This article was originally published in PharmAsia News
Executive Summary
Thailand's new health minister has made it clear he intends to use the country's compulsory licensing law to ensure Thais have access to key drugs at lower prices. Public Health Minister Chaovarat Chanweerakul's stance on the issue had been doubted by non-government organizations that feared he would side with drug makers and not use the CL policy. But at Chaovarat's arrival on the job, he promised he would break patents on life-saving drugs when necessary. (Click here for more
You may also be interested in...
Sanofi Asks Thailand To Review Compulsory Licensing Policy
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.